comparison of efficacy of pistacia atlantial oleoresin with that of placebo in treatment of patients with functional dyspepsia
Early Phase 1
Recruiting
- Conditions
- Functional dyspepsia.
- Registration Number
- IRCT20210124050126N1
- Lead Sponsor
- Bagheiat-allah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Age 15 to 65 years,
Patients with ROME4 criteria including recurrent abdominal pain that recurs on average at least once a week for at least three months
abdominal pain associated with bowel movements and the frequency and appearance of bowel movements
any abdominal discomfort, any Abdominal discomfort species
Exclusion Criteria
IBS, PUD, GERD CHF, DM, ATHMA, COPD and, , , ,
Psychological diseases
history of alcohol and opium addiction
,gastrointestinal surgery
need for continuous use of cardiological drugs
antihypertensive
antipsychotic sedatives
antibiotics
corticosteroids
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Flatulence, premature satiety, loss of appetite. Timepoint: 2 and 4 weeks after starting to use L Pistacia atlantica gum. Method of measurement: Hong Kong Questionnaire.
- Secondary Outcome Measures
Name Time Method Quality of Life. Timepoint: 2 and 4 weeks after the onset of gum. Method of measurement: Quality of Life Questionnaire sf-36.